EGRX
Eagle Pharmaceuticals, Inc.
EGRX
EGRX
Delisted
EGRX was delisted on the 2nd of October, 2024.
175 hedge funds and large institutions have $1.21B invested in Eagle Pharmaceuticals, Inc. in 2017 Q2 according to their latest regulatory filings, with 36 funds opening new positions, 76 increasing their positions, 42 reducing their positions, and 5 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more call options, than puts
Call options by funds: $ | Put options by funds: $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding in top 10
Funds holding in top 10: →
19% more funds holding
Funds holding: 147 → 175 (+28)
11% less capital invested
Capital invested by funds: $1.36B → $1.21B (-$152M)
Holders
175
Holding in Top 10
4
Calls
$12.4M
Puts
$4.72M
Top Buyers
| 1 | +$144M | |
| 2 | +$65M | |
| 3 | +$22.7M | |
| 4 |
Lazard Asset Management
New York
|
+$20M |
| 5 |
Morgan Stanley
New York
|
+$12.8M |
Top Sellers
| 1 | -$55.7M | |
| 2 | -$10M | |
| 3 | -$8.23M | |
| 4 |
PI
Putnam Investments
Boston,
Massachusetts
|
-$6.5M |
| 5 |
PWAM
Park West Asset Management
San Francisco,
California
|
-$6.43M |